Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 4.3000 |
| 開市 | 4.1400 |
| 買盤 | 3.8300 x 700 |
| 賣出價 | 3.8800 x 900 |
| 今日波幅 | 3.7800 - 4.1500 |
| 52 週波幅 | 1.6300 - 8.8300 |
| 成交量 | |
| 平均成交量 | 2,798,469 |
| 市值 | 489.269M |
| Beta 值 (5 年，每月) | 1.68 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.4800 |
| 業績公佈日 | 2024年5月01日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 7.80 |
ZacksFate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
ZacksWhy Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksWhy Is Myriad (MYGN) Down 1% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
